Ignite Creation Date:
2024-05-06 @ 12:37 AM
Last Modification Date:
2024-10-26 @ 10:52 AM
Study NCT ID:
NCT01615874
Status:
WITHDRAWN
Last Update Posted:
2022-02-16
First Post:
2012-06-07
Brief Title:
Study of the Effect of Mometasone FuroateFormoterol MFF Montelukast and Beclomethasone Dipropionate BDP on Plasma Cortisol Levels of Children 5-11 Years Old With Persistent Asthma P05574
Sponsor:
Organon and Co
Organization:
Organon and Co
Study Overview
Official Title:
A Six-week Evaluator-Blind Randomized Active-Controlled Evaluation of the Effects of Three Doses of Mometasone FuroateFormoterol Fumarate MFF Metered Dose Inhaler MDI Montelukast and Beclomethasone Dipropionate BDP HFA on the HPA Axis in Asthmatic Children 5 to 11 Years of Age Protocol No P05574PN158
Status:
WITHDRAWN
Status Verified Date:
2022-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to assess the effect of one of five possible study medications used in the treatment of asthma on blood plasma cortisol levels in children aged 5-11 years with persistent asthma
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2009-010108-27 | EUDRACT_NUMBER | None | None |